Xu Jiang

744 total citations
21 papers, 347 citations indexed

About

Xu Jiang is a scholar working on Molecular Biology, Neurology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Xu Jiang has authored 21 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Neurology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Xu Jiang's work include Myasthenia Gravis and Thymoma (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Peripheral Neuropathies and Disorders (3 papers). Xu Jiang is often cited by papers focused on Myasthenia Gravis and Thymoma (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Peripheral Neuropathies and Disorders (3 papers). Xu Jiang collaborates with scholars based in China, United States and Japan. Xu Jiang's co-authors include Hirofumi Okada, Masahiro Nogawa, Yasushi Morikawa, Naoya Takakuwa, Zhuyi Li, Haiteng Deng, Hong Lin, Shan Feng, Yuanjie Sun and Feng Tian and has published in prestigious journals such as PLoS ONE, Applied Microbiology and Biotechnology and Chemical Science.

In The Last Decade

Xu Jiang

19 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu Jiang China 10 190 140 89 62 49 21 347
Stefanie Fischer Germany 7 272 1.4× 37 0.3× 65 0.7× 17 0.3× 11 0.2× 11 374
T. Tsuchida Japan 10 106 0.6× 68 0.5× 37 0.4× 19 0.3× 6 0.1× 23 317
Xiao Qin United Kingdom 11 174 0.9× 71 0.5× 44 0.5× 48 0.8× 4 0.1× 21 406
Dalila Iannotta United States 10 251 1.3× 47 0.3× 6 0.1× 40 0.6× 6 0.1× 14 380
Dmitry Genkin Russia 11 159 0.8× 26 0.2× 23 0.3× 151 2.4× 3 0.1× 15 364
Jinbae Son Australia 7 174 0.9× 53 0.4× 48 0.5× 27 0.4× 4 0.1× 8 264
Katia Cheaito Lebanon 9 175 0.9× 56 0.4× 22 0.2× 14 0.2× 14 0.3× 12 369
Youngsoon Jang United States 9 243 1.3× 35 0.3× 9 0.1× 58 0.9× 4 0.1× 13 323

Countries citing papers authored by Xu Jiang

Since Specialization
Citations

This map shows the geographic impact of Xu Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Jiang more than expected).

Fields of papers citing papers by Xu Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Jiang. The network helps show where Xu Jiang may publish in the future.

Co-authorship network of co-authors of Xu Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Jiang. A scholar is included among the top collaborators of Xu Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Jiang. Xu Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lang, Haili, Jie Zeng, Yuqi Wen, et al.. (2025). Oleracein E Rejuvenates Senescent Hippocampal NSCs by Inhibiting the ERK1/2‐mTOR Axis to Improve Cognitive Dysfunction in Vascular Dementia. European Journal of Neuroscience. 61(9). e70137–e70137.
2.
Li, Xia, Xuewen Yu, Xu Jiang, et al.. (2024). Integrating single‐cell and spatial transcriptomes reveals COL4A1/2 facilitates the spatial organisation of stromal cells differentiation in breast phyllodes tumours. Clinical and Translational Medicine. 14(3). e1611–e1611. 7 indexed citations
3.
Jiang, Xu, Xinyue Xiao, Hao Li, et al.. (2023). Oxidized galectin-1 in SLE fails to bind the inhibitory receptor VSTM1 and increases reactive oxygen species levels in neutrophils. Cellular and Molecular Immunology. 20(11). 1339–1351. 11 indexed citations
4.
Zhao, Qing, Huazhen Liu, Ziyue Zhou, et al.. (2022). Cancer occurrence after SLE: effects of medication-related factors, disease-related factors and survival from an observational study. Lara D. Veeken. 62(2). 659–667. 4 indexed citations
5.
Ni, Junjun, Liangwei Yang, Huangkai Zhu, et al.. (2021). A patient with metastatic non-small cell lung cancer who received pembrolizumab monotherapy after stereotactic body radiotherapy had progression-free survival of nearly 5 years: a case report. Annals of Palliative Medicine. 10(4). 4999–5009. 6 indexed citations
6.
Xiao, Xinyue, Yueting Li, Xu Jiang, et al.. (2020). EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis. Journal of Autoimmunity. 108. 102404–102404. 51 indexed citations
7.
Ye, Lin, Chen Song, Xu Jiang, et al.. (2017). Irrelevance of anti-nAChR cytoplasmic loop antibody in the degree of myasthenia gravis. International Journal of Molecular Medicine. 40(3). 931–939.
8.
Jiang, Xu, Shan Feng, Yuling Chen, Yun Feng, & Haiteng Deng. (2016). Proteomic analysis of mTOR inhibition-mediated phosphorylation changes in ribosomal proteins and eukaryotic translation initiation factors. Protein & Cell. 7(7). 533–537. 12 indexed citations
9.
Jiang, Xu, et al.. (2016). Proteomic Analysis of eIF5B Silencing-Modulated Proteostasis. PLoS ONE. 11(12). e0168387–e0168387. 9 indexed citations
10.
Jiang, Xu, Jia Li, Xingan Wu, et al.. (2015). Expression and refolding of bioactive α-bungarotoxin V31 in E. coli. Protein Expression and Purification. 110. 30–36. 4 indexed citations
11.
Zhang, Xiaoyan, Shasha Liu, Ting Chang, et al.. (2014). Intrathymic Tfh/B Cells Interaction Leads to Ectopic GCs Formation and Anti-AChR Antibody Production: Central Role in Triggering MG Occurrence. Molecular Neurobiology. 53(1). 120–131. 46 indexed citations
12.
13.
Li, Lan, Xuanling Shi, Senyan Zhang, et al.. (2012). Role of Human CD4 D1D2 Domain in HIV-1 Infection. Immunological Investigations. 42(2). 106–121. 2 indexed citations
14.
Song, Chen, Zhikai Xu, Jianting Miao, et al.. (2011). Protective effect of scFv‐DAF fusion protein on the complement attack to acetylcholine receptor: A possible option for treatment of myasthenia gravis. Muscle & Nerve. 45(5). 668–675. 12 indexed citations
15.
Chang, Ting, Hong Lin, Jie Gao, et al.. (2010). Selective recognition and elimination of nicotinic acetylcholine receptor-reactive B cells by a recombinant fusion protein AChR-Fc in myasthenia gravis in vitro. Journal of Neuroimmunology. 227(1-2). 35–43. 2 indexed citations
16.
Jiang, Xu, et al.. (2009). An improved method for refolding recombinant decay accelerating factor for therapeutic studies. Protein Expression and Purification. 66(1). 102–106. 1 indexed citations
17.
Zhang, Wei, Jianting Miao, Jian Hao, et al.. (2009). Protective effect of S14G-humanin against beta-amyloid induced LTP inhibition in mouse hippocampal slices. Peptides. 30(6). 1197–1202. 21 indexed citations
18.
Ogasawara, Wataru, Yosuke Shida, Takanori Furukawa, et al.. (2006). Cloning, functional expression and promoter analysis of xylanase III gene from Trichoderma reesei. Applied Microbiology and Biotechnology. 72(5). 995–1003. 36 indexed citations
19.
Jiang, Xu, Masahiro Nogawa, Hirofumi Okada, & Yasushi Morikawa. (2000). Regulation of xyn3 gene expression in Trichoderma reesei PC-3-7. Applied Microbiology and Biotechnology. 54(3). 370–375. 47 indexed citations
20.
Jiang, Xu, Naoya Takakuwa, Masahiro Nogawa, Hirofumi Okada, & Yasushi Morikawa. (1998). A third xylanase from Trichoderma reesei PC-3-7. Applied Microbiology and Biotechnology. 49(6). 718–724. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefanie Fischer Breakdown of academic impact, for papers by T. Tsuchida Breakdown of academic impact, for papers by Xiao Qin Breakdown of academic impact, for papers by Dalila Iannotta Breakdown of academic impact, for papers by Dmitry Genkin Breakdown of academic impact, for papers by Jinbae Son Breakdown of academic impact, for papers by Katia Cheaito Breakdown of academic impact, for papers by Youngsoon Jang
Rankless by CCL
2026